Ole Dahlberg

Ole Dahlberg

Founder at
Qvint Biotech AS

Net worth: 33 952 $ as of 31/08/2026

Health Technology
Commercial Services
Consumer Services

Profile

Ole Jesper Dahlberg is the founder of Cytomics Pharmaceuticals SA, founded in 2000.
Mr. Dahlberg is also the founder of Qvint Biotech AS.
Current jobs include Chairman at Nadeno Nanoscience AS since 2023 and Chairman at Curida.
AS since 2022.
Former jobs include Chief Executive Officer at Mole Genetics AS, Director at Medistim ASA, Senior Scientist at Orchid Cellmark, Inc., and Vice President-Sales at Qiagen, Inc. Education includes a graduate degree from the University of Oslo, conferred in 1997.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
31/12/2024 1,240 ( 0.01% ) 33 952 $ 31/08/2026

Ole Dahlberg active positions

CompaniesPositionStart
Qvint Biotech AS
Founder 23/07/2009
Chairman 01/02/2023
Chairman 01/02/2022

Former positions of Ole Dahlberg

CompaniesPositionEnd
MEDISTIM ASA Director/Board Member 08/05/2025
Founder 10/10/2011
Sales & Marketing -
Corporate Officer/Principal -
President -
See the detail of Ole Dahlberg's experience

Training of Ole Dahlberg

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

54

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Qvint Biotech AS

Health Technology

Health Technology

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!